KorstanjeM.J., van Breda VriesmanC.J., van de StaaakW.J.Cyclosporine and MTX: A dangerous combination.J Am Acad Derm1990; 23(2 part 1): 320–1.
2.
International Kidney Biopsy Registry of Cyclosporin in Autoimmune Diseases.Renal morphology after cyclosporin A therapy in rheumatoid arthritis patients.Br J Rheumatol1993; 32(Supp 1): 65–71.
3.
ZachariaeH., HansenH., KragballeK., OlsenS.Morphologic renal changes during cyclosporine treatment of psoriasis.J Am Acad Dermatol1992; 26: 415–9.
4.
SteinC.M., BrooksR.H., PincusT.Effect of combination therapy with cyclosporine and MTX on liver function test results in rheumatoid arthritis.Arthritis Rheum1997; 40(9): 1721–3.
5.
KlintmalmG.B., IwatsukiS., StarzlT.E.Cyclosporin A hepatotoxicity in 66 renal allograft recipients.Transplantation1981; 32: 488–9.
6.
ClarkC.M., KirbyB., MorrisA.D.. Combination treatment with MTX and cyclosporine for severe recalcitrant psoriasis.Br J Dermatol1999; 141(2): 279–82.
7.
TugwellP., PincusT., YocumD.. Combination therapy with cyclosporine and MTX in severe rheumatoid arthritis.N Eng J Med1995; 333(3): 137–41.
8.
ReemG.H., CookL.A., VilcekJ.Gamma interferon synthesis by human thymocytes and T lymphocytes inhibited by cyclosporine A.Science1983; 221: 63–5.
9.
KremerJ.M., PetrilloG.F., LawrenceD.A.MTX (MTX) induces significant changes in IL-1, IL-2, IL-6, and IL-8, but not lymphocyte markers in patients with rheumatoid arthritis (RA).Arthritis Rheum1993; 36(Suppl): S77, abstract.
10.
WongK.C., GeorgourasK.Low dose cyclosporine A and MTX in the treatment of psoriasis.Acta Derm Venereol (Stockh).1998; 79: 87.
11.
SalaffiF., CarottiM., CerviniC.Combination therapy of cyclosporine A with MTX or hydroxychloroquine in refractory rheumatoid arthritis.Scand J Rheum1996; 25: 16–23.
12.
BensenW., TugwellP., RobertsR.M.. Combination therapy of cyclosporin with MTX and gold in rheumatoid arthritis (2 pilot studies).J Rheumatol1994; 21: 2034–8.
13.
BoffaM.J., ChalmersR.J.G.MTX therapy for psoriasis.Clin Exp Dermatol1996; 21: 399–408.
14.
LebwohlM., EllisC., GottliebA.. Cyclosporine consensus conference: with emphasis on the treatment of psoriasis.J Am Acad Dermatol1998; 39(3): 464–75.
15.
LeavellU.W., YarbroJ.W.Hydroxyurea: a new treatment for psoriasis.Arch Dermatol1970; 102: 144–50.
16.
DahlM.G.C., ComaishJ.S.Long-term effects of hydroxyurea in psoriasis.Br Med J1972; 4: 585–7.
17.
LaytonA.M., Sheehan-DareR.A., GoodfieldM.J.D.. Hydroxyurea in the management of therapy resistant psoriasis.Br J Derm1989; 121: 647–53.
18.
SmithC.H.Use of hydroyxurea in psoriasis.Clin Exper Dermatol1999; 24: 2–6.
MenterM.A., SeeJ., AmendW.J.. Proceedings of the psoriasis combination and rotation therapy conference.J Am Acad Dermatol1996; 34(2): 315–21.
21.
KirbyB., HarrisonP.V.Combination low-dose cyclosporin (Neoral) and hydroxyurea for severe recalcitrant psoriasis.Br J Dermatol1999; 140: 168–92.
22.
MorelandL.W., BaumgartnerS.W., SchiffM.H.. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p-75)-Fc fusion protein.N Engl J Med1997; 337: 141–7.
23.
WeinblattM.E., KremerJ.M., BankhurstA.D.. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving MTX.N Engl J Med1999; 340(4): 253–9.
24.
JarvisB., FauldsD.Etanercept: a review of its use in rheumatoid arthritis.Drugs1999; 57(6): 945–66.
25.
MorelandL.W., SchiffM.H., BaumgartnerS.W.. Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.Ann Int Med1999; 130(6): 478–86.
26.
MeaseP.J., GoffeB.S., MetzJ.. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial.Lancet2000; 356: 385–9.
